Evaluation of the reintroducing FOLFOX or XELOX +/- BV in relapsed colorectal cancer patients treated with oxaliplatin as adjuvant chemotherapy.(REACT study)
Latest Information Update: 19 Feb 2019
At a glance
- Drugs Bevacizumab (Primary) ; Capecitabine; Fluorouracil; Folinic acid; Oxaliplatin
- Indications Colorectal cancer
- Focus Therapeutic Use
- Acronyms REACT study
- 19 Jan 2019 Results presented at the 2019 Gastrointestinal Cancers Symposium
- 19 Jan 2019 Status changed from active, no longer recruiting to completed.
- 18 Apr 2017 Status changed from recruiting to active, no longer recruiting.